Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Aldeyra"


2 mentions found


Companies Aldeyra Therapeutics Inc FollowJune 15 (Reuters) - Aldeyra Therapeutics (ALDX.O) said on Thursday its treatment for an inflammatory eye disease met the main goal of reducing itching in a late-stage study, sending its shares up 16% in premarket trading. The liquid eye drop formulation, reproxalap, is being developed to treat allergic conjunctivitis that leads to swelling in a tissue lining the eyelids and white layer of the eye. The treatment also helped reduce redness and tearing caused due to the disease when compared with placebo, the company said. Reporting by Mariam Sunny in Bengaluru Editing by Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.
Persons: Mariam Sunny, Vinay Dwivedi Organizations: Aldeyra Therapeutics, Thomson Locations: Bengaluru
Cognyte Software — Shares rose 5.6% in the premarket following the software company's quarterly report. American Express — Shares of the credit card company dipped 2% in premarket trading after Citi warned that credit card spending trends have slowed. Citi opened a negative catalyst watch for American Express, warning that travel and entertainment categories are slowing more sharply than other categories. SoFi — Shares slid 4% after Oppenheimer downgraded the financial technology stock to perform from outperform. Zions Bancorp — The bank stock slid 1.4% in the premarket.
Persons: Cognyte, Wall, Aldeyra, Mizuho, SoFi, Oppenheimer, Janney, , Sarah Min, Michelle Fox, Jesse Pound Organizations: FactSet, Therapeutics, Citi, American Express, Stifel, Corning, Zions Bancorp, Bancorp Locations: Wednesday's
Total: 2